Purpose: is study examined genetic associations of patatin-like phospholipase domain containing 3 gene(PNPLA3) polymorphisms and liver aminotransferases in an extensively documented, randomly recruited Mexican American population at high risk of liver disease.
e Hispanic population, and Mexican Americans in particular, have high rates of obesity, diabetes, metabolic syndrome (MetS) and liver disease, particularly non-alcoholic fatty liver disease (NAFLD) [1] [2] [3] [4] [5] . e patatin-like phospholipase domain containing 3 gene (PNPLA3) at Chr22q13.31 was originally identi ed in adipose tissue by Baulande et al. and named adiponutrin [6] . is gene is speci cally expressed in adipose tissue and is under tight nutritional regulation [6] . What implicates PNPLA3 in liver disease is that, in 2008, Romeo et al. identi ed an association between an amino acid substitution I[Ile]148M [Met] (NCBI dbSNP ID: rs738409) in the PNPLA3 gene and genetic susceptibility for NAFLD [7] . is observation was con rmed in a number of subsequent reports [8] [9] [10] [11] [12] [13] . Recent functional experiments showed that the I148M substitution from the single nucleotide polymorphism (SNP) rs738409 caused a loss of enzymatic activity [14] . Studies have also showed an association of PNPLA3 variations with increased plasma levels of liver enzymes [15, 16] . e strongest signal of the quantitative trait association was tagged by the SNP rs2281135. Genetic association of a PNPLA3 variant with alcoholic liver disease was also proposed [17] . Together these interesting observations suggest that PNPLA3 might encode a key molecule mediating the pathological processes of liver injury in metabolic disorders.
Given the high rate of NAFLD in Hispanics, the genetic association of PNPLA3 SNPs and liver enzymes was examined in a well-studied cohort of Mexican Americans: the Cameron County Hispanic Cohort (CCHC) from the Lower Rio Grande Valley (LRGV) in south Texas, USA [18] . e participants of this cohort were randomly recruited in the city of Brownsville, Cameron County, based on the 2000 census tract data. In this population,a 49.5% prevalence of obesity, a 30.7% prevalence of diabetes and a high incidence of abnormal serum liver enzymes were observed [3, 19, 20] . Assessing the genetic e ect of PNPLA3 variants in this population may lead to further understanding of genetic drivers of liver injury in this underserved minority population.
Materials and Methods
Subjects is study investigated 1532 individuals from the CCHC. e characteristics of this cohort have been extensively described in previous reports [18, 19, 21] . e participants were randomly selected from this population and no disease criteria were applied in their selection; therefore, the participants are representative of the general population of the town. Blood samples were obtained at recruitment. Informed consent was obtained from each individual, and the Committee for the Protection of Human Subjects of the University of Texas Health Science Center at Houston (UTHealth) approved this study.
Genotyping e genotyping for this study was done using the Sequenom iPLEX assay (Sequenom, Cambridge, MA).Two single nucleotide polymorphisms (SNP) in the PNPLA3 gene (i.e., rs738409 and rs2281135)were genotyped. rs738409 was the SNP I148M that was originally identi ed as having genetic association with NAFLD [7] . e other SNP, rs2281135, was identi ed as the strongest association in this genetic region with elevated ALT by a genome-wide association study in a European population [15] . As is shown by HapMap data, rs738409 and rs2281135 are in tight linkage disequilibrium (LD) in three major human ethnic groups: African, Caucasian and East Asian (Table 1) . e genotyping call rates of both SNPs were 100%. e Mexican Americans in our study are an admixed population of predominantly European and Native American ancestry. To address the potential bias of population strati cation, 103 continental ancestry informative markers (AIMs) for Mexican Americans, identi ed by a previous study [22] , were genotyped. All these AIMs are on autochromosomes. e genotyping call rates of the 103 AIM SNPs were between 95.4% and 100%, with a median of 99.9%. For the purpose of quality control, 93 DNA samples were genotyped in duplicate and the concordance rate of each duplicate was 100%.
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Statistical methods e population structure of the Mexican American population was analyzed by principal component analysis using the Eigenso version 2.0 so ware [19] . uantitative trait association t e s t s w e r e p e r f o r m e d u s i n g P L I N K s o w a r e (http://pngu.mgh.harvard.edu/~purcell/plink/). e additive genetic model was used in the association test. All association test results were adjusted for age. CCHC participants showed the predominant one-dimensional character of an admixture of European and American Indian ancestries. e rst principal component (PC1) explained the majority of population structure; therefore, all association test results in this study were corrected for PC1.
Results
Sex di erence in liver injury was observed in our previous epidemiological analyses of this population [3, 19] . Previous studies have also suggested a possibility of sex di erence in the genetic association of PNPLA3 and liver enzymes [23] . In our study, signi cant sex-SNP interaction was observed: rs738409-sex interaction in ALT levels had P=8.37x10 -4 ; rs738409-sex interaction in AST levels had P=5.03x10 -3 ; therefore, genetic e ects were assessed separately in males and females. By the quantitative trait association test, PNPLA3 SNPs showed highly signi cant association with ALT levels in both males and females (Table 2) . Association between the PNPLA3 SNPs and AST levels was also statistically signi cant in males; however, the genetic association between the PNPLA3 SNPs and AST levels was not seen in females. e sex di erence in AST association has a statistical signi cance of p=0.024 for rs738409, and p=0.055 for rs2281135. Table 1 shows that two PNPLA3 SNPs, rs738409 and rs2281135, are in tight linkage disequilibrium (LD) in these Mexican Americans -similar to that seen in three other major human ethnic groups: African, Caucasian and East Asian. e genetic association was replicated in haplotypic association tests ( Table 3) . As shown by the haplotypic association tests, the direction of the genetic e ect of two haplotypes carrying the same C allele of rs738409 is the same, but this is not the case for the two haplotypes carrying the same C allele of rs2281135. e ALT associations of the rs738409-rs2281135 haplotypes C-C vs. G-C are heterogeneous with highly statistical signi cances (p=2.97 x 10 -5 in males, and p=5.89 x 10 -6 in females). e AST associations of the two haplotypes were also heterogeneous with statistical signi cances (p=2.36 x 10 -5 in males, and p=0.076 in females).
To further examine the e ect of sex on ALT association, step-wise logistic regression analyses were performed by taking a series of cuto s of ALT or AST values for classi cation (Table 4). Corrected forage and population structure, the logistic regression analysis also suggested a sex e ect. Interestingly, using the traditional cuto of over 40U/L as denoting elevated ALT, the association of rs738409 or rs2281135 with elevated ALTwas not signi cant in males (p=0.187 for rs738409, p=0.164 for rs2281135), but was highly signi cant in females (p =1.72 x 10 -5 for rs738409, p=1.30 x 10 -5 for rs2281135). When a higher cuto value was used, a high statistical signicance was also seen in the logistic regression in males. e PNPLA3 SNP rs738409 has a stronger association with considerably more elevated ALT levels in males in comparison with females. A similar trend towards much higher elevation in males was also observed in the association with AST levels. As we have already shown in this Mexican American population, obesity, insulin resistance, and the metabolic syndrome (MetS) are common [3, 19] . We have also shown that in this population the ratio between plasma levels of two key adipokines, adiponectin and leptin is critical in MetS [21] . To determine how these metabolic disorders might be related to the genetic association of PNPLA3 polymorphisms and liver enzymes, the association amongthe PNPLA3 SNPs and Body Mass Index (BMI), the homeostasis model assessmentestimated insulin resistance (HOMA-IR), adiponectin, leptin, and Log(leptin/adiponectin) were tested. A er correcting forage and population structure, no genetic association was identi ed between PNPLA3 polymorphisms and BMI, HOMA-IR, adiponectin and leptin (Table 5 ).
Li et al. Polymorphisms and Liver Enzymes in Mexican
e genetic association of rs738409 and ALT in women≤50 years old versus women>50 years old were then compared, to test the theory that sex hormone levels may be responsible for gender di erences. Although not measured in these subjects, it is assumed that there are signi cant di erences in estrogen levels in these two age groups. A strong genetic association was found in women≤50 years old (β=0.202, P=1.69x10 -7 ), but not in women>50 years old (β=0.060, P=0.231).
Discussion
is study shows that the association between PNPLA3 polymorphisms and elevated plasma liver enzymes is highly statistically signi cant in a Mexican American population and that that population structure of this admixed sample has no obvious e ect on this association. Furthermore, the haplotypic association test suggests the genetic association tagged by the two PNPLA3 SNPs represents a single genetic e ect. Interestingly a sex e ect of PNPLA3 polymorphisms was also observed, which was further characterized in detail in this Mexican American population.
Phospholipase A2 (PLA2) catalyzes the hydrolysis of the sn-2 position of membrane glycerophospholipids to yield arachidonic acid (AA) and lysophospholipids [24] . AA is a precursor of eicosanoids, including prostaglandins (PGs) and leukotrienes (LTs). Lysophospholipids are potent biologically active lipid mediators that exert a wide range of cellular e ects through speci c G protein-coupled receptors [25] . In the PLA2 enzyme superfamily, six families of PLA2,with di erent action mechanisms and biological activities, have been identied [26] . PNPLA3 encodes a member of the CalciumIndependent PLA2 (iPLA2) family and the iPLA2 enzymes have been known to play a major role in membrane phospholipid remodeling [27] . PNPLA3 was originally identi ed in adipose tissue as Adiponutrin [6] , where its expression is under tight nutritional regulation. In the fasting status, PNPLA3 mRNA is almost undetectable, but increases dramatically a er a high carbohydrate challenge [6] . Studies have shown triacylglycerol (TAG) lipase activity and acylglyceroltransacylase activity of the PNPLA3 protein [28] . Important insight into PNPLA3 involvement in liver lipid metabolism comes from the recent genetic studies: the derived allele of SNP rs738409 in PNPLA3 was found to be associated with increased liver fat content [7, 13] , NAFLD [7] [8] [9] [10] [11] [12] [13] and increased plasma levels of liver enzymes [15, 16] . Functional experiments showed that the I148M substitution from SNP rs738409 caused a loss of enzyme activity [14] .
Prior to our study, a meta-analysis by Sookoian and Pirola suggested the possibility of sex di erence in the genetic association of PNPLA3 polymorphisms and liver enzymes; that is, a negative association between the e ect of rs738409 on liver fat content and male sex using meta-regression analysis [23] . Our study con rms and advances this observation by showing that the PNPLA3 SNPs have a stronger association with more highly elevated ALT levels in males, but are not associated with moderately elevated ALT in males. A recent report by Huang et al. showed that, in mice, nutritional control of PNPLA3 expression in liver was regulated by a feed-forward loop that couples transcriptional and posttranslational controls. e transcription factor SREBP-1c plays key roles by directly activating PNPLA3 transcription and indirectly inhibiting PNPLA3 degradation through the stimulation of fatty acid synthesis [29] . Transcription of PNPLA3 is regulated by the transcription factor, sterol regulatory element binding protein 1c (SREBP-1c) [29] . SREBP-1c is a direct target gene of the liver X receptor (LXR) /retinoid X receptor (RXR) heterodimer [30] . Transcriptional regulation of PNPLA3 by fasting and refeeding requires both SREBP-1c and LXR/RXR [29] . Estrogen can cause down-regulation of expression of both LXR and SREBP-1c [31] . is sex hormone mediated mechanism may explain the interesting sex e ect characterized in this study.
In human adipose tissue, PNPLA3 mRNA expression is also known to be regulated by energy intake. PNPLA3 mRNA levels have not been found to be di erent between non-obese and obese women, and do not correlate with adiposity indexes or leptin or adiponectin mRNAs [32] . Our data provides further evidence that obesity, insulin resistance and adipose disorder are not involved in this genetic association of liver enzymes. Although MetS has a high prevalence and is the major common factor in liver injury in our population [3, 21] , our data suggest PNPLA3-mediated liver enzyme change is independent of these common pathological factors of MetS.
To our knowledge, this is the rst study of the genetic association of PNPLA3 polymorphisms and liver enzymes using material from a community cohort in a small USA city with a high minority population and a relatively homogenous culture and life-style.
is homogeneity makes this population a unique resource for biomarker studies [19, 21] . Besides the genetic e ect of PNPLA3 polymorphism, a number of other factors were found to be involved in elevated liver enzymes in this population, including plasma insulin level and insulin resistance, BMI and body weight, serum triglycerides and non-HDL cholesterol and hypertension. A er correction for these factors, the genetic e ect from PNPLA3 polymorphism was found to be independent (e.g. rs738409and ALT levels P=2.00x10 -7 ) [33] .
Our study had a number of limitations. 1. Diet is a risk factor of NAFLD; However, there was no robust method to measure diet in this community population. 2. We did not identify the association of the PNPLA3 variant and AST in measurement of ad diponectin and females. 3. Plasma AST level lacks speci city for liver injury, as AST is found widely in multiple tissues: red blood cells, liver, heart, muscle tissue, pancreas and kidneys. 4. Although an interesting sex-speci c e ect of the PNPLA3 variant, underlying mechanisms could not be characterized further with existing data. Sex hormone may mediate the sex e ect, however, data concerning plasma sex hormone levels in our cohort participants was not available. Trying to partially compensate for this, the genetic association of rs738409 and ALT were compared in women≤50 years old versus women>50 years old, suggests that, if sex hormones are involved in liver injury, endogenous estrogen is not protective in liver injury in women.
